# Nemus: Form D filings

Nemus, a pharmaceuticals company in Costa Mesa, CA, filed 2 Form D notices with the SEC in 2014. The latest, on October 20, 2014, reports $455,100 sold of a $455,100 offering to 18 investors.

Find out what Nemus does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Nemus%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Nemus&page=%2Fdata%2Fform-d%2Fcompany%2Fnemus-1611294)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Nemus%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Nemus&page=%2Fdata%2Fform-d%2Fcompany%2Fnemus-1611294)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 650 Town Center Drive, Suite 620, Costa Mesa, CA, 92626
- Phone: (310) 948-2274
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: California
- Year incorporated: 2012
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1611294

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 20, 2014 | New notice | $455,100 | $455,100 | $0 | 18 | Oct 7, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1611294/000114036114038569/0001140361-14-038569-index.htm) |
| Jun 27, 2014 | New notice | $2,000,000 | $1,486,000 | $514,000 | 12 | Jun 13, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1611294/000114036114026813/0001140361-14-026813-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Elizabeth Berecz | Executive Officer |  |
| Cosmas Lykos | Executive Officer, Director |  |
| Reg Lapham | Promoter |  |
| John Hollister | Executive Officer, Director |  |
| Brian Murphy | Executive Officer |  |
| Jerry McLaughlin | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Oct 20, 2014](https://specstream.ai/data/form-d/week/2014-10-20) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Nemus reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).